Company: XTIA
Filing Date: 2025-09-12
Form Type: 424B5
Source: 0001213900-25-087270
Chunk: 13

Company: XTI Aerospace, Inc.
Filing Date: 2025-09-12
Form: 424B5
Chunk 13
---
 by reference in this prospectus supplement     
 and the accompanying prospectus for a discussion of factors you should carefully consider before investing our securities.               |
| Nasdaq                
 Capital Market symbol |     | Our common stock is listed                                                                                                               
 on The Nasdaq Capital Market under the symbol “XTIA.”                                                                                    |
|                       |     | There is no established trading market for the Pre-funded Warrants                                                                       
 or the Common Warrants, and we do not expect a trading market to develop. We do not intend to list the Pre-funded Warrants or the Common 
 Warrants on any securities exchange or nationally recognized trading system.                                                             |

| (1) | The number of shares of                                                                                                             
 common stock that will be outstanding after this offering is based on 20,253,316 shares of common stock outstanding as of September 
 10, 2025, and excludes as of such date:                                                                                             |

| ● | 9,657,946                                                                                                                               
 shares of common stock issuable upon the exercise of outstanding stock options at a weighted average exercise price of $3.78 per share; |

| ● | 11,250,616                                                                                                                         
 shares of common stock issuable upon the exercise of outstanding warrants at a weighted average exercise price of $4.14 per share; |

| ● | 63,299,184                                                                                                                           
 shares of common stock available for future issuance under our 2018 Employee Stock Incentive Plan and any other additional shares of 
 our common stock that may become available under our 2018 Employee Stock Incentive Plan;                                             |

| ● | 1                                                                                                                                        
 share of common stock issuable upon the conversion of 1 outstanding share of Series 4 Convertible Preferred Stock, at a conversion price 
 of $418,500,000 per share; and                                                                                                           |

| ● | 1                                                                                                                                       
 share of common stock issuable upon conversion of 126 outstanding shares of Series 5 Convertible Preferred Stock, at a conversion price 
 of $280,968,750 per share.                                                                                                              |

Unless otherwise indicated, this prospectus reflects and assumes the following:

| ● | no exercise of outstanding 
 options or warrants;       |

| ● | no sale of any Pre-funded           
 Warrants in this proposed offering; |

| ● | no exercise of the Common Warrants issued and sold in this offering; 
 and                                                                  |

| ● | no exercise of the Placement                                                                                                          
 Agent Warrants to be issued upon consummation of this offering at an exercise